The partnership will allow doctors to prescribe the CBD by BRITISH CANNABIS™ products to patients via the Treat It platform. From November, Treat It will also be included in Canndr, an online medicinal cannabis app from BRITISH CANNABIS™ which enables patients to select and review quality cannabis medicines on the market, gain consultancy advice and select from a number of suitable prescribing clinics. Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce that it has entered into a partnership with BRITISH CANNABIS™ to supply the CBD by BRITISH CANNABIS™ range of pharmacy-grade CBD health supplements to patients via a prescription service through the Group’s online pain management clinic, Treat It. By incorporating CBD by BRITISH CANNABIS™ products into our offerings, Kanabo continues to increase the accessibility and affordability of high quality, alternative pain management solutions to improve overall patient quality of life. Focused on secondary care, Treat It enables patients access to healthcare professionals via its secure, digital healthcare platform.
Kanabo Group plc (LSE: KNB), the patient-focused provider of digital health services and specialist medicines, including medicinal cannabis, is pleased to announce that it has entered into a partnership with BRITISH CANNABIS™ to supply the CBD by BRITISH CANNABIS™ range of pharmacy-grade CBD health supplements to patients via a prescription service through the Group’s online pain management clinic, Treat It.
The partnership will allow doctors to prescribe the CBD by BRITISH CANNABIS™ products to patients via...
Read the full article @ Cannabis Law Report